Viva Cyte Programska platforma Suite – avtor Livia Stevenin

Delo Viva Cyte Programska platforma Suite avtorja Livia Stevenin je izjemno cenjeni dobitnik prestižne nagrade 2025 Srebrna nagrada A' Design Award v tekmovalni kategoriji Oblikovanje vmesnikov, interakcij in uporabniške izkušnje.

SrebrnaVmesnik· 2025

Viva Cyte Programska platforma Suite

avtor/ica: Livia Stevenin

Naročnik: Cellply

Dobitnik nagrade Srebrna nagrada A' Design Award v kategoriji Vmesnik

56,621

Potrjeni dobitnik nagrade

Preverite status nagrade za #168358

Obiščite spletno stran Ogled na A' Design Award Sporočilo za javnost Značka nagrade

Barve

Dizajn

O dizajnu Viva Cyte Programska platforma Suite

Viva Cyte je napredna programska platforma, zasnovana za poenostavitev razvoja celične terapije z integracijo avtomatizacije, analize z visokim pretokom in intuitivne uporabniške izkušnje. Sestavljena je iz nadzorne programske opreme (CSW) za upravljanje bioloških testov in analitične programske opreme (ASW) za pridobivanje pomembnih vpogledov. Avtomatizacija, ki jo poganja umetna inteligenca, zmanjšuje človeške napake, izboljšuje natančnost in povečuje uporabnost ter raziskovalcem omogoča učinkovito obvladovanje zapletenih delovnih tokov, hkrati pa pospeši terapevtski napredek.

Priznanje

O nagradi Srebrna nagrada A' Design Award

Viva Cyte Programska platforma Suite je prejemnik Srebrne nagrade A' Design Award, izjemno prestižnega priznanja, ki se podeljuje čudovitim, impresivnim vrhunskim oblikovanjem. Prejemniki Srebrne nagrade so izjemno briljantna in zelo ustvarjalna dela, ki ponazarjajo izjemno strokovnost, talent in bistrost svojih oblikovalcev. Od Viva Cyte Programska platforma Suite se pričakuje, da bo čudovito, zgledno delo, opazno profesionalno in globoko inovativno. To oblikovanje, nagrajeno s Srebrno nagrado A' Design Award, je zelo opazen, občudovan izum, ki koristi in premika meje umetnosti, znanosti, oblikovanja in tehnologije. Viva Cyte Programska platforma Suite je stvaritev, ki ji mnogi zavidajo, ki prebuja želje, prinaša pozitivna čustva in vzbuja začudenje in občudovanje.

V ozadju dizajna

Komplet za medije

Zasluge, člani ekipe in tehnične podrobnosti, ki jih je posredoval oblikovalec.

Edinstvene lastnosti: The project focused on UX/UI design for two integrated software solutions: Control Software (CSW) for launching and managing biological tests and Analytical Software (ASW) for extracting key insights from results. The design prioritizes scalability, usability, and automation and enables researchers to navigate complex workflows, configure tests, and analyze data with minimal effort, streamlining the entire process.
Dimenzije in embalaža: Design: Figma
Front-end: React JS
Design System: Bento
Oznake: Cell therapy software, AI-driven automation, biomedical research, UX/UI design, data-driven, workflow optimization, healthcare innovation, regulatory compliance, user-centered design
Proizvodna tehnologija: We conducted extensive user research to design VivaCyte's software suite, including shadowing biologists in labs and interviewing end-users to understand their workflows and challenges. We also organized User Journey Mapping workshops, bringing together biologists and development teams to foster collaboration and gather diverse perspectives. The insights from these activities guided the creation of a custom design system, ensuring consistency and usability across the platforms.
Oblikovalski izziv: Designing VivaCyte posed challenges in balancing usability, automation, and compliance. Internally, we had to align complex biological workflows with intuitive design, ensuring seamless lab adoption. Externally, strict medical regulations require adherence to compliance standards. Limited industry precedents and evolving AI capabilities pushed us to innovate with user research, iterative prototyping, and AI-driven automation, overcoming barriers in technology and regulatory constraints.
Raziskave: We conducted user research to enhance VivaCyte’s usability and efficiency. Using shadowing and interviews, we observed lab workflows and identified pain points. Data was collected via on-site studies, journey mapping, and prototype testing with biologists and technicians. Insights led to features like printable maps and a guided setup walkthrough, reducing errors and improving efficiency. The research optimized workflows, accelerating cell therapy development.
Inspiracija: Inspired by the need to accelerate cancer cell therapies, VivaCyte was designed to streamline workflows, reduce human error, and enhance patient care. Recognizing the challenges of complex, labour-intensive workflows in cell therapy development, we sought to create a solution that integrates advanced automation, high-throughput analysis, and intuitive design. The design prioritizes usability and scalability, enabling researchers and clinicians to focus on innovation rather than constraints.
Trajanje projekta: The project started in January 2022 in Milan and finished in August 2024.
Potek delovanja: VivaCyte streamlines cell therapy workflows through an intuitive, automated interface. Users launch tests via the Control Software (CSW), which configures experiments that can be followed in real-time, while the Analytical Software (ASW) extracts biological insights and displays them. AI-driven automation minimizes errors, ensuring accuracy and efficiency. Designed for seamless interaction, it simplifies complex tasks, accelerates data analysis, and enhances usability.
Člani ekipe: Designer: Sara Bianchini
Designer: Livia Stevenin
Designer: Agnese Ragucci
Zasluge za slike: Image #1: Mockup: Designed by Freepik, Image: Livia Stevenin (UX/UI designer), Image #2: Livia Stevenin (UX/UI designer), Image #3: Livia Stevenin (UX/UI designer), Image #4: Livia Stevenin (UX/UI designer), Image #5: Livia Stevenin (UX/UI designer),